Evidence map›Paper›PMID 30026477›Full record

ArticleNature immunology2018

Comment on: Evidence of innate lymphoid cell redundancy in humans.

Jordan S Orange, Emily M Mace, Anthony R French, Wayne M Yokoyama, Todd A Fehniger, Megan A Cooper

Abstract readLetterComment
In one paragraph

Article in Nature immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Human natural killer cells: Form, function, and development.The Journal of allergy and clinical immunology · 2023
    Review
  4. Article
  5. Antiviral Activities of Group I Innate Lymphoid Cells.Journal of molecular biology · 2022
    Review
  6. Review
  7. How I Manage Natural Killer Cell Deficiency.Journal of clinical immunology · 2020
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Jordan S OrangeDepartment of Pediatrics, Columbia University, New York, NY, USA.
Emily M MaceDepartment of Pediatrics, Columbia University, New York, NY, USA.
Anthony R FrenchDepartment of Pediatrics, Division of Rheumatology, Washington University, St. Louis, MO, USA.
Wayne M YokoyamaDepartment of Medicine, Division of Rheumatology, Washington University, St. Louis, MO, USA.
Todd A FehnigerDepartment of Medicine, Division of Oncology, Washington University, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-8705-2887
Megan A CooperDepartment of Pediatrics, Division of Rheumatology, Washington University, St. Louis, MO, USA. cooper_m@wustl.edu.ORCID http://orcid.org/0000-0002-5696-172X

Funding

Targeting the Bone Marrow Microenvironment In Acute Lymphocytic LeukemiaP50CA171963 · NCI · WASHINGTON UNIVERSITY · PI TODD A FEHNIGER · 2013 to 2026
$31.6M
GENETIC, IMMUNOLOGIC AND MECHANISTIC BASIS OF HUMAN NK CELL DEFICIENCYR01AI120989 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ORANGE, JORDAN SCOTT · 2016 to 2025
$7.7M
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTIONR01AI078994 · NIAID · WASHINGTON UNIVERSITY · PI FRENCH, ANTHONY R · 2009 to 2019
$3.8M
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPYR01CA205239 · NCI · WASHINGTON UNIVERSITY · PI FEHNIGER, TODD A · 2017 to 2020
$2.4M
METABOLIC REGULATION OF NATURAL KILLER CELL ACTIVATIONR01AI127752 · NIAID · WASHINGTON UNIVERSITY · PI COOPER, MEGAN ANNE · 2017 to 2021
$1.9M
NCI NIH HHS P50 CA171963NCI NIH HHS R01 CA205239NIAID NIH HHS R01 AI078994NIAID NIH HHS R01 AI120989NIAID NIH HHS R01 AI127752
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunity, InnateLymphocytesHumans

Identifiers

PMID30026477
PMCPMC6736524

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.